UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Regulation and roles of RNA modifications in aging‐related diseases

Aging cell, 2022-07, Vol.21 (7), p.e13657-n/a

2022

Volltextzugriff (PDF)

Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center

Journal of neuro-oncology, 2018-12, Vol.140 (3), p.639-647

2018

Volltextzugriff (PDF)

Long-term outcomes of multimodality management for parasagittal meningiomas

Journal of neuro-oncology, 2020-04, Vol.147 (2), p.441-450

2020

Volltextzugriff (PDF)

Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)

Chinese medical journal, 2022-08, Vol.135 (16), p.1894-1912

2022

Volltextzugriff (PDF)

Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma

Biomedicine & pharmacotherapy, 2022-11, Vol.155, p.113843-113843, Article 113843

2022

Volltextzugriff (PDF)

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma

Cancer medicine (Malden, MA), 2019-01, Vol.8 (1), p.13-20

2019

Volltextzugriff (PDF)

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas

Frontiers in oncology, 2022-09, Vol.12, p.879528-879528

2022

Volltextzugriff (PDF)

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway

Molecules and Cells, 2022, 45(6), , pp.388-402

2022

Volltextzugriff (PDF)

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy

Frontiers in oncology, 2021-10, Vol.11, p.747592-747592

2021

Volltextzugriff (PDF)

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma

Frontiers in oncology, 2020-11, Vol.10, p.568079-568079

2020

Volltextzugriff (PDF)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma

Frontiers in oncology, 2020-09, Vol.10, p.542294

2020

Volltextzugriff (PDF)

m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes

Frontiers in oncology, 2021-12, Vol.11, p.760892-760892

2021

Volltextzugriff (PDF)

Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application

Expert opinion on biological therapy, 2019-08, Vol.19 (8), p.845-854

2019

Volltextzugriff (PDF)

A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma

Targeted oncology, 2019-08, Vol.14 (4), p.479-489

2019

Volltextzugriff (PDF)

Prognostic factors in patients with primary hemangiopericytomas of the central nervous system: a series of 103 cases at a single institution

World neurosurgery, 2016-06, Vol.90, p.414-419

2016

Volltextzugriff (PDF)

The Diagnostic Value Of Using 18F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma

Cancer management and research, 2019-01, Vol.11, p.9185-9193

2019

Volltextzugriff (PDF)

IRAK4 exacerbates traumatic brain injury via activation of TAK1 signaling pathway

Experimental neurology, 2022-05, Vol.351, p.114007-114007, Article 114007

2022

Volltextzugriff (PDF)

Letter to the Editor Regarding “Stereotactic Radiosurgery for Atypical and Anaplastic Meningiomas”

World neurosurgery, 2020-12, Vol.144, p.324-324

2020

Volltextzugriff (PDF)

MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma

Neuro-oncology (Charlottesville, Va.), 2021-12, Vol.23 (12), p.2014-2027

2021

Volltextzugriff (PDF)

Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection

Journal of neurosurgery, 2023-07, Vol.139 (1), p.49-58

2023

Volltextzugriff (PDF)

Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes

Neurosurgery, 2023-04, Vol.92 (4), p.745-755

2023

Volltextzugriff (PDF)

Predicting meningioma grades and pathologic marker expression via deep learning

European radiology, 2024-05, Vol.34 (5), p.2997-3008

2024

Volltextzugriff (PDF)

Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma

World neurosurgery, 2023-08, Vol.176, p.e501-e514

2023

Volltextzugriff (PDF)

The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study

Journal of neuro-oncology, 2024, Vol.166 (1), p.59-71

2024

Volltextzugriff (PDF)

SURG-11. AKT1 E17K AND NF2 MUTATIONS DOMINATE SPINAL MENINGIOMAS WHO GRADE 1 AND PRESENT DISTINCT TUMOR FEATURES

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii253-vii253

2022

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(48)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regulation and roles of RNA modifications in aging‐related diseases

Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center

Long-term outcomes of multimodality management for parasagittal meningiomas

Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)

Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma

m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes

Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application

A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma

Prognostic factors in patients with primary hemangiopericytomas of the central nervous system: a series of 103 cases at a single institution

The Diagnostic Value Of Using 18F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma

IRAK4 exacerbates traumatic brain injury via activation of TAK1 signaling pathway

Letter to the Editor Regarding “Stereotactic Radiosurgery for Atypical and Anaplastic Meningiomas”

MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma

Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection

Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes

Predicting meningioma grades and pathologic marker expression via deep learning

Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma

The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study

SURG-11. AKT1 E17K AND NF2 MUTATIONS DOMINATE SPINAL MENINGIOMAS WHO GRADE 1 AND PRESENT DISTINCT TUMOR FEATURES

Suchergebnisse filtern